E-LIB Suche - Ergebnisse für: Short, N.

1

Dorsal Column Myelopathy Following Intrathecal Chemotherapy..:

Schrank, B.R. ; Manzar, G.S. ; Wu, S.Y....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. e486-e487 , 2023

Link: https://doi.org/10.1016/..

2

P566: IMPACT OF FRONTLINE INDUCTION APPROACH ON POST-STEM C..:

Ong, F. ; Ravandi, F. ; Popat, U....
HemaSphere. 6 (2022) - p. 465-466 , 2022

Link: https://doi.org/10.1097/..

3

P754: INITIAL RESULTS OF PHASE I/II STUDY OF AZACITIDINE IN..:

Abuasab, T. ; Jabbour, E. ; Short, N....
HemaSphere. 6 (2022) - p. 649-650 , 2022

Link: https://doi.org/10.1097/..

4

P369: A PHASE II STUDY OF MINI-HYPER-CVD PLUS VENETOCLAX IN..:

Senapati, J. ; Kantarjian, H. ; Short, N....
HemaSphere. 6 (2022) - p. 269-270 , 2022

Link: https://doi.org/10.1097/..

5

P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGI..:

Ravandi, F. ; Jabbour, E. ; Jain, N....
HemaSphere. 6 (2022) - p. 265-266 , 2022

Link: https://doi.org/10.1097/..

6

P355: MINI-HYPER-CVD PLUS INOTUZUMAB OZOGAMICIN, WITH OR WI..:

Haddad, F. ; Kantarjian, H. ; Short, N....
HemaSphere. 6 (2022) - p. 255-256 , 2022

Link: https://doi.org/10.1097/..

7

S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADEL..:

Short, N. ; Kantarjian, H. ; Konopleva, M....
HemaSphere. 6 (2022) - p. 15-16 , 2022

Link: https://doi.org/10.1097/..

8

PB1831: UTILITY OF FLT3 INHIBITORS IN PATIENTS WITH ACUTE M..:

Ong, F. ; Kadia, T. M. ; Short, N. J....
HemaSphere. 6 (2022) - p. 1711-1712 , 2022

Link: https://doi.org/10.1097/..

9

P770: A COMPARATIVE STUDY OF LEUKEMIC TRANSFORMATION IN THE..:

Kim, K. ; Ong, F. ; Li, Z....
HemaSphere. 6 (2022) - p. 665-666 , 2022

Link: https://doi.org/10.1097/..

10

P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WI..:

Bazinet, A. ; Jabbour, E. ; Kantarjian, H....
HemaSphere. 6 (2022) - p. 652-653 , 2022

Link: https://doi.org/10.1097/..

11

P367: LONG TERM OUTCOMES OF NEWLY DIAGNOSED CRLF2 REARRANGE..:

Senapati, J. ; Jabbour, E. J. ; Short, N. J....
HemaSphere. 6 (2022) - p. 267-268 , 2022

Link: https://doi.org/10.1097/..

12

P695: PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN CHRONIC PHASE..:

Bidikian, A. ; Kantarjian, H. ; Jabbour, E....
HemaSphere. 6 (2022) - p. 590-591 , 2022

Link: https://doi.org/10.1097/..

13

P784: A PHASE I/II STUDY OF VENETOCLAX IN COMBINATION WITH ..:

Venugopal, S. ; kantarjian, H. ; Maiti, A....
HemaSphere. 6 (2022) - p. 679-680 , 2022

Link: https://doi.org/10.1097/..

14

S127: QUIZARTINIB WITH DECITABINE AND VENETOCLAX (TRIPLET) ..:

Yilmaz, M. ; Muftuoglu, M. ; Kantarjian, H....
HemaSphere. 6 (2022) - p. 28-29 , 2022

Link: https://doi.org/10.1097/..

15

P368: A PHASE II STUDY OF INOTUZUMAB OZOGAMICIN FOR THE TRE..:

Senapati, J. ; Kantarjian, H. ; Short, N....
HemaSphere. 6 (2022) - p. 268-269 , 2022

Link: https://doi.org/10.1097/..